124 related articles for article (PubMed ID: 9713302)
1. Ki-ras mutations and prognosis in colorectal cancer.
Kressner U; Bjørheim J; Westring S; Wahlberg SS; Påhlman L; Glimelius B; Lindmark G; Lindblom A; Børresen-Dale AL
Eur J Cancer; 1998 Mar; 34(4):518-21. PubMed ID: 9713302
[TBL] [Abstract][Full Text] [Related]
2. Heterogeneity of mutant versus wild-type Ki-ras in primary and metastatic colorectal carcinomas, and association of codon-12 valine with early mortality.
Al-Mulla F; Going JJ; Sowden ET; Winter A; Pickford IR; Birnie GD
J Pathol; 1998 Jun; 185(2):130-8. PubMed ID: 9713338
[TBL] [Abstract][Full Text] [Related]
3. p53 and Ki-ras as prognostic factors for Dukes' stage B colorectal cancer.
Bouzourene H; Gervaz P; Cerottini JP; Benhattar J; Chaubert P; Saraga E; Pampallona S; Bosman FT; Givel JC
Eur J Cancer; 2000 May; 36(8):1008-15. PubMed ID: 10885605
[TBL] [Abstract][Full Text] [Related]
4. Kirsten ras mutations in patients with colorectal cancer: the multicenter "RASCAL" study.
Andreyev HJ; Norman AR; Cunningham D; Oates JR; Clarke PA
J Natl Cancer Inst; 1998 May; 90(9):675-84. PubMed ID: 9586664
[TBL] [Abstract][Full Text] [Related]
5. Kirsten ras mutations in patients with colorectal cancer: the 'RASCAL II' study.
Andreyev HJ; Norman AR; Cunningham D; Oates J; Dix BR; Iacopetta BJ; Young J; Walsh T; Ward R; Hawkins N; Beranek M; Jandik P; Benamouzig R; Jullian E; Laurent-Puig P; Olschwang S; Muller O; Hoffmann I; Rabes HM; Zietz C; Troungos C; Valavanis C; Yuen ST; Ho JW; Croke CT; O'Donoghue DP; Giaretti W; Rapallo A; Russo A; Bazan V; Tanaka M; Omura K; Azuma T; Ohkusa T; Fujimori T; Ono Y; Pauly M; Faber C; Glaesener R; de Goeij AF; Arends JW; Andersen SN; Lövig T; Breivik J; Gaudernack G; Clausen OP; De Angelis PD; Meling GI; Rognum TO; Smith R; Goh HS; Font A; Rosell R; Sun XF; Zhang H; Benhattar J; Losi L; Lee JQ; Wang ST; Clarke PA; Bell S; Quirke P; Bubb VJ; Piris J; Cruickshank NR; Morton D; Fox JC; Al-Mulla F; Lees N; Hall CN; Snary D; Wilkinson K; Dillon D; Costa J; Pricolo VE; Finkelstein SD; Thebo JS; Senagore AJ; Halter SA; Wadler S; Malik S; Krtolica K; Urosevic N
Br J Cancer; 2001 Sep; 85(5):692-6. PubMed ID: 11531254
[TBL] [Abstract][Full Text] [Related]
6. Ki-ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancer.
Gnanasampanthan G; Elsaleh H; McCaul K; Iacopetta B
J Pathol; 2001 Dec; 195(5):543-8. PubMed ID: 11745689
[TBL] [Abstract][Full Text] [Related]
7. Transitions and transversions in Ki-ras gene in colorectal cancers in Mexican patients.
Segura-Uribe J; Santiago-Payán H; Quintero A
Tumori; 2003; 89(3):259-62. PubMed ID: 12908779
[TBL] [Abstract][Full Text] [Related]
8. Relevance of Ki-67 antigen expression and K-ras mutation in colorectal liver metastases.
Petrowsky H; Sturm I; Graubitz O; Kooby DA; Staib-Sebler E; Gog C; Köhne CH; Hillebrand T; Daniel PT; Fong Y; Lorenz M
Eur J Surg Oncol; 2001 Feb; 27(1):80-7. PubMed ID: 11237496
[TBL] [Abstract][Full Text] [Related]
9. Ki-ras codon 12 point mutational activation in Hong Kong colorectal carcinoma patients.
Ko JM; Cheung MH; Wong CM; Lau KW; Tang CM; Kwan MW; Lung ML
Cancer Lett; 1998 Dec; 134(2):169-76. PubMed ID: 10025877
[TBL] [Abstract][Full Text] [Related]
10. Relationships between c-Ki-ras mutations, HPV types, and prognostic indicators in invasive endocervical adenocarcinomas.
Koulos JP; Wright TC; Mitchell MF; Silva E; Atkinson EN; Richart RM
Gynecol Oncol; 1993 Mar; 48(3):364-9. PubMed ID: 8385060
[TBL] [Abstract][Full Text] [Related]
11. Specific codon 13 K-ras mutations are predictive of clinical outcome in colorectal cancer patients, whereas codon 12 K-ras mutations are associated with mucinous histotype.
Bazan V; Migliavacca M; Zanna I; Tubiolo C; Grassi N; Latteri MA; La Farina M; Albanese I; Dardanoni G; Salerno S; Tomasino RM; Labianca R; Gebbia N; Russo A
Ann Oncol; 2002 Sep; 13(9):1438-46. PubMed ID: 12196370
[TBL] [Abstract][Full Text] [Related]
12. Distinctive clinicopathological features of Ki-ras mutated colorectal cancers.
Lin JK; Chang SC; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC; Li AF
J Surg Oncol; 2006 Sep; 94(3):234-41. PubMed ID: 16900509
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of c-Ki-ras2 mutations in patients with advanced colorectal cancer treated with 5-fluorouracil and interferon: a study of the eastern cooperative oncology group (EST 2292).
Wadler S; Bajaj R; Neuberg D; Agarwal V; Haynes H; Benson AB
Cancer J Sci Am; 1997; 3(5):284-8. PubMed ID: 9327152
[TBL] [Abstract][Full Text] [Related]
14. Type and number of Ki-ras point mutations relate to stage of human colorectal cancer.
Moerkerk P; Arends JW; van Driel M; de Bruïne A; de Goeij A; ten Kate J
Cancer Res; 1994 Jul; 54(13):3376-8. PubMed ID: 8012953
[TBL] [Abstract][Full Text] [Related]
15. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.
Atkins D; Breuckmann A; Schmahl GE; Binner P; Ferrone S; Krummenauer F; Störkel S; Seliger B
Int J Cancer; 2004 Mar; 109(2):265-73. PubMed ID: 14750179
[TBL] [Abstract][Full Text] [Related]
16. K-ras mutations and prognosis in large-bowel carcinomas.
Andersen SN; Løvig T; Breivik J; Lund E; Gaudernack G; Meling GI; Rognum TO
Scand J Gastroenterol; 1997 Jan; 32(1):62-9. PubMed ID: 9018769
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of microsatellite instability and Ki-ras mutation type in stage II colorectal cancer.
Wang C; van Rijnsoever M; Grieu F; Bydder S; Elsaleh H; Joseph D; Harvey J; Iacopetta B
Oncology; 2003; 64(3):259-65. PubMed ID: 12697967
[TBL] [Abstract][Full Text] [Related]
18. Predominance of G to A codon 12 mutation K-ras gene in Dukes' B colorectal cancer.
Zulhabri O; Rahman J; Ismail S; Isa MR; Wan Zurinah WN
Singapore Med J; 2012 Jan; 53(1):26-31. PubMed ID: 22252179
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.
Catalano T; Curia MC; Aceto G; Verginelli F; Cascinu S; Cama A; Mariani-Costantini R; Teti D; Battista P
Oncol Rep; 2005 Sep; 14(3):625-31. PubMed ID: 16077965
[TBL] [Abstract][Full Text] [Related]
20. The prognostic significance of K-ras, p53, and APC mutations in colorectal carcinoma.
Conlin A; Smith G; Carey FA; Wolf CR; Steele RJ
Gut; 2005 Sep; 54(9):1283-6. PubMed ID: 15843421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
